Growing, evolving and sticking in a flowing environment: understanding IgA interactions with bacteria in the gut.


Journal

Immunology
ISSN: 1365-2567
Titre abrégé: Immunology
Pays: England
ID NLM: 0374672

Informations de publication

Date de publication:
01 2020
Historique:
received: 01 08 2019
revised: 13 10 2019
accepted: 14 10 2019
pubmed: 30 11 2019
medline: 6 2 2020
entrez: 29 11 2019
Statut: ppublish

Résumé

Immunology research in the last 50 years has made huge progress in understanding the mechanisms of anti-bacterial defense of deep, normally sterile, tissues such as blood, spleen and peripheral lymph nodes. In the intestine, with its dense commensal microbiota, it seems rare that this knowledge can be simply translated. Here we put forward the idea that perhaps it is not always the theory of immunology that is lacking to explain mucosal immunity, but rather that we have overlooked crucial parts of the mucosal immunological language required for its translation: namely intestinal and bacterial physiology. We will try to explain this in the context of intestinal secretory antibodies (mainly secretory IgA), which have been described to prevent, to alter, to not affect, or to promote colonization of the intestine and gut-draining lymphoid tissues, and where effector mechanisms have remained elusive. In fact, these apparently contradictory outcomes can be generated by combining the basic premises of bacterial agglutination with an understanding of bacterial growth (i.e. secretory IgA-driven enchained growth), fluid handling and bacterial competition in the gut lumen.

Identifiants

pubmed: 31777063
doi: 10.1111/imm.13156
pmc: PMC6904610
doi:

Substances chimiques

Immunoglobulin A, Secretory 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-62

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Références

Front Immunol. 2013 Aug 06;4:222
pubmed: 23964273
Cell Host Microbe. 2016 Apr 13;19(4):550-9
pubmed: 27053168
Trends Immunol. 2016 May;37(5):287-296
pubmed: 27066758
Nature. 2017 Apr 27;544(7651):498-502
pubmed: 28405025
Cell Host Microbe. 2019 May 8;25(5):656-667.e8
pubmed: 31028005
Sci Rep. 2019 Sep 19;9(1):13574
pubmed: 31537840
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):E2774-83
pubmed: 22991466
Appl Environ Microbiol. 2002 Jul;68(7):3401-7
pubmed: 12089021
Cell Host Microbe. 2007 Nov 15;2(5):328-39
pubmed: 18005754
Cell Host Microbe. 2017 Oct 11;22(4):494-506.e8
pubmed: 28966055
Gut. 1992 Jun;33(6):818-24
pubmed: 1624166
Annu Rev Immunol. 2018 Apr 26;36:359-381
pubmed: 29400985
Infect Immun. 2008 Sep;76(9):4137-44
pubmed: 18625740
Curr Opin Microbiol. 2011 Apr;14(2):205-11
pubmed: 21292543
Nature. 2018 Mar 29;555(7698):623-628
pubmed: 29555994
Cell Host Microbe. 2019 Feb 13;25(2):195-209
pubmed: 30763534
Gut Microbes. 2014 Jan-Feb;5(1):28-39
pubmed: 24637807
ISME J. 2016 Jun;10(6):1413-23
pubmed: 26623546
J Immunol. 2007 Dec 1;179(11):7751-7
pubmed: 18025221
Biophys J. 2016 Aug 9;111(3):630-639
pubmed: 27508446
J Exp Med. 2018 Aug 6;215(8):2019-2034
pubmed: 30042191
Mucosal Immunol. 2020 Jan;13(1):3-11
pubmed: 31413347
Viruses. 2018 Dec 25;11(1):
pubmed: 30585199
Science. 2010 Jun 25;328(5986):1705-9
pubmed: 20576892
Nat Biotechnol. 2016 Dec;34(12):1256-1263
pubmed: 27819664
FEMS Microbiol Rev. 1988 Sep;4(3):195-222
pubmed: 3078744
J R Soc Interface. 2019 Jul 26;16(156):20190182
pubmed: 31288652
Immunity. 2018 Sep 18;49(3):545-559.e5
pubmed: 30193848
J Lab Clin Med. 1973 May;81(5):733-46
pubmed: 4698660
Sci Transl Med. 2018 May 2;10(439):
pubmed: 29720448
Science. 2018 May 18;360(6390):795-800
pubmed: 29724905
Science. 2015 Sep 4;349(6252):1101-1106
pubmed: 26229116
PLoS Pathog. 2014 Dec 18;10(12):e1004557
pubmed: 25522364
PLoS Comput Biol. 2019 May 3;15(5):e1006986
pubmed: 31050663
Gastroenterology. 1993 Oct;105(4):988-98
pubmed: 8405884
Science. 2017 Oct 20;358(6361):
pubmed: 28971969
Science. 2017 Mar 17;355(6330):1211-1215
pubmed: 28302859
Immunol Lett. 2009 Jun 4;124(2):57-62
pubmed: 19524784
Immunity. 2018 Aug 21;49(2):211-224
pubmed: 30134201
Nat Microbiol. 2019 Sep;4(9):1571-1581
pubmed: 31160824
Front Immunol. 2016 Feb 11;7:34
pubmed: 26904024
Trends Immunol. 2018 Mar;39(3):196-208
pubmed: 29162322
Cell Host Microbe. 2017 Apr 12;21(4):443-454
pubmed: 28407482
Gastroenterology. 1967 Dec;53(6):856-67
pubmed: 4863722
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20236-41
pubmed: 24259713
Cell. 2014 Aug 28;158(5):1000-1010
pubmed: 25171403
Proc Natl Acad Sci U S A. 2017 Jun 20;114(25):6438-6443
pubmed: 28588144
Infect Immun. 2013 Mar;81(3):653-64
pubmed: 23230292
Front Microbiol. 2018 Feb 02;9:82
pubmed: 29467727
Front Immunol. 2012 May 03;3:100
pubmed: 22563329
Cell. 2018 Jun 14;173(7):1742-1754.e17
pubmed: 29906449
Sci Transl Med. 2019 Aug 28;11(507):
pubmed: 31462512
Nat Med. 2019 Jul;25(7):1110-1115
pubmed: 31209335
Nat Microbiol. 2020 Sep;5(9):1170-1181
pubmed: 32601452
Nat Rev Microbiol. 2008 Feb;6(2):121-31
pubmed: 18180751
PLoS Pathog. 2010 Sep 09;6(9):e1001097
pubmed: 20844578
Cell. 2013 Jan 17;152(1-2):39-50
pubmed: 23332745
Trends Microbiol. 2018 Dec;26(12):1008-1021
pubmed: 30037568
Mucosal Immunol. 2011 Nov;4(6):603-11
pubmed: 21975936
Annu Rev Immunol. 2010;28:107-30
pubmed: 19968562
Science. 2018 Nov 30;362(6418):
pubmed: 30498100
Appl Environ Microbiol. 2001 Oct;67(10):4939-42
pubmed: 11571208

Auteurs

Daniel Hoces (D)

Department of Health Sciences and Technology, Institute of Food, Nutrition and Health, ETH Zürich, Zürich, Switzerland.

Markus Arnoldini (M)

Department of Health Sciences and Technology, Institute of Food, Nutrition and Health, ETH Zürich, Zürich, Switzerland.

Médéric Diard (M)

Biozentrum, University of Basel, Basel, Switzerland.

Claude Loverdo (C)

Laboratoire Jean Perrin, Sorbonne Université/CNRS, Paris, France.

Emma Slack (E)

Department of Health Sciences and Technology, Institute of Food, Nutrition and Health, ETH Zürich, Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH